Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OBINUTUZUMAB Cause Wrong technique in product usage process? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Wrong technique in product usage process have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.0% of all adverse event reports for OBINUTUZUMAB.

5
Reports of Wrong technique in product usage process with OBINUTUZUMAB
0.0%
of all OBINUTUZUMAB reports
0
Deaths
1
Hospitalizations

How Dangerous Is Wrong technique in product usage process From OBINUTUZUMAB?

Of the 5 reports, 1 (20.0%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does OBINUTUZUMAB Cause?

Off label use (1,584) Neutropenia (1,276) Febrile neutropenia (955) Covid-19 (942) Pyrexia (920) Thrombocytopenia (889) Disease progression (831) Infusion related reaction (789) Pneumonia (662) Anaemia (640)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which OBINUTUZUMAB Alternatives Have Lower Wrong technique in product usage process Risk?

OBINUTUZUMAB vs OCELLA OBINUTUZUMAB vs OCRELIZUMAB OBINUTUZUMAB vs OCRIPLASMIN OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE

Related Pages

OBINUTUZUMAB Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process OBINUTUZUMAB Demographics